Author | Ali McBride, PharmD, MS, BCOP | OncLive

Author | Ali McBride, PharmD, MS, BCOP

Articles

Dr. McBride on Biosimilar Rituximab

September 27, 2019

Video

Ali McBride, PharmD, MS, BCOP, discusses the oncology community’s reaction to biosimilars for rituximab (Rituxan).

Dr. McBride on the Potential Impact of Bevacizumab Biosimilars in Oncology

August 09, 2019

Video

Ali McBride, PharmD, MS, BCOP, Clinical Coordinator of Hematology/Oncology, The University of Arizona Cancer Center, and President-Elect of the Association of Community Cancer Centers (ACCC), discusses the potential impact of bevacizumab (Avastin) biosimilars in oncology.

Dr. McBride Discusses Financial Toxicity in Oncology

June 14, 2018

Video

Ali McBride, PharmD, MS, BCOP, Clinical Coordinator of Hematology/Oncology, The University of Arizona Cancer Center, and President-Elect of the Association of Community Cancer Centers.

x